How soon after the last injection of Ripped 150 should PCT begin?

PCT should begin approximately 3–5 days after the final injection of Ripped 150. Because all three esters — Testosterone Propionate, Trenbolone Acetate, and Drostanolone Propionate — carry short carbon chains (2- or 3-carbon), de-esterification and plasma clearance occur within days. Waiting longer than 5 days risks extending HPG axis suppression unnecessarily. An aggressive SERM protocol is mandatory from day one of PCT.

What blood markers confirm that Ripped 150 has cleared and PCT can safely start?

LH, FSH, and total testosterone are the primary markers to assess before starting PCT. After the last Ripped 150 injection, LH and FSH should begin recovering as exogenous androgen levels fall. A blood panel drawn 3–5 days post-injection provides a practical confirmation window. If total testosterone remains suppressed at day 5, a SERM should be initiated regardless, as the short esters will have cleared by this point.

What happens pharmacologically if PCT is started too early — before ester clearance is complete?

Starting PCT while residual ester is still releasing active hormone creates a counterproductive overlap: circulating androgens continue suppressing LH and FSH even as a SERM attempts to stimulate their release. With Ripped 150's short esters this risk is minimal beyond 48 hours, but users who inject large volumes on the final day should still wait the full 3–5 day window to allow complete de-esterification before initiating the SERM protocol.

Why is Ripped 150's 150mg/ml concentration an advantage for precise per-compound dosing?

At 150mg/ml — the lowest concentration in its product category — Ripped 150 delivers exactly 50mg per compound per ml, making dose calculation straightforward and injection volumes manageable. Users targeting 150mg total per injection draw precisely 1ml; those splitting doses to every-other-day can administer 0.5ml, yielding 25mg of each compound. This clarity reduces measurement error and supports consistent bioavailability across each injection day.

How should a 10ml vial of Ripped 150 be stored after the first puncture to maintain solution integrity?

After the first puncture, Ripped 150 should be stored at room temperature away from direct light and heat sources — refrigeration is not required and can increase oil viscosity, making withdrawal more difficult. The rubber stopper maintains multi-dose integrity; however, the vial should be used within the manufacturer's recommended period once opened. Inspect the solution before each draw: any cloudiness or particulates indicate the vial should be discarded immediately. (2) angle_used

Precision Formula

Magnus Pharmaceuticals

Ripped 150 150mg/ml 10ml Vial by Magnus Pharmaceuticals

Name: Ripped 150 150mg/ml 10ml Vial by Magnus Pharmaceuticals
Brand: Magnus Pharmaceuticals
SKU: INJ-MIX-MAG-150-006
Price: 65.00 EUR
Availability: InStock

Magnus Pharmaceuticals Ripped 150 is a 150mg/ml injectable cutting vial — Testosterone Propionate 50mg/ml, Trenbolone Acetate 50mg/ml, and Drostanolone Propionate 50mg/ml — packaged in a 10ml multi-dose format, with each compound selected for its rapid de-esterification kinetics and immediate intramuscular onset rather than depot longevity. Because acetate and propionate ester chains hydrolyse within days of the final injection, HPG axis recovery begins earlier than with long-ester cycles, allowing post-cycle therapy to be initiated around a defined 3–5 day clearance window. Magnus Pharmaceuticals enforces batch-level quality controls at every production stage: HPLC quantification of each compound fraction, LAL endotoxin testing, and sterility verification are completed per lot before any unit is released.

€65.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Three-phase hormonal release from a single injection — acetate leads, propionates extend.
Complete hepatic first-pass bypass via intramuscular route — 100% systemic bioavailability.
Short carbon-chain esters enable precise 3–5 day PCT initiation windows.
1,500mg total active content per vial at a manageable 150mg/ml injection concentration.
Each compound independently HPLC-verified per batch under Magnus Pharmaceuticals' Swiss-standard QA.
LAL endotoxin testing confirms sterility of every production batch before release.
Predictable plasma concentration peaks support structured, science-based training cycles.

Phase	Dosage	Note
Bioavailability Loading — Early Cycle	0.5–1ml (75–150mg total) every other day	Short ester onset within 24 hours; assess individual tolerance to rapid androgen elevation during first two weeks.
Active Cutting Phase	1ml (150mg total) every other day	Maintain consistent injection frequency to preserve stable plasma levels across all three ester bioavailability windows.
Taper / Final Week	0.5ml (75mg total) every other day	Reducing dose in the final 7 days allows plasma levels to descend ahead of PCT, shortening the clearance-to-PCT gap toward the lower end of the 3–5 day window.
Post-Cycle Transition	No injection — PCT begins day 3–5	Aggressive SERM protocol mandatory; blood panel (LH, FSH, total testosterone) recommended on day 3 to confirm ester clearance.

Key takeaways

Choose Ripped 150 for three simultaneous bioavailability phases per injection.
Expect rapid hormone onset within 24 hours due to acetate and propionate ester kinetics.
Schedule PCT precisely 3–5 days after the final injection for optimal HPG recovery.
Confirm clearance via LH, FSH, and testosterone blood panel before starting SERM.
Draw 1ml per injection for an exact 50mg dose of each active compound.

What Makes Ripped 150 a Bioavailability-Optimised Cutting Blend

Magnus Pharmaceuticals Ripped 150 is a bioavailability-first tri-ester injectable that combines Testosterone Propionate 50mg/ml, Trenbolone Acetate 50mg/ml, and Drostanolone Propionate 50mg/ml into a single 150mg/ml solution — a formulation architecture in which every ester was selected specifically for its rapid de-esterification kinetics rather than for depot longevity. Intramuscular administration bypasses hepatic first-pass metabolism entirely, meaning 100% of the injected dose enters systemic circulation as intact ester, compared to oral androgens that lose a significant fraction to gut-wall and liver enzymes before reaching the bloodstream. Magnus Pharmaceuticals applies a Swiss-aligned quality standard to each 10ml vial, with HPLC quantification confirming that all three active fractions are within specification at batch release.

Three Short Esters — Three Distinct Bioavailability Windows

The ester architecture of Ripped 150 delivers a structured, three-phase hormonal release from a single injection. Trenbolone Acetate, carrying a 2-carbon acetic acid chain, undergoes de-esterification and reaches peak plasma concentration fastest — typically within 24 hours of administration. Testosterone Propionate and Drostanolone Propionate, each bearing a 3-carbon propionic acid chain, follow with a slightly extended release window that sustains circulating androgen levels into the 48–72 hour range. This staggered bioavailability profile means users experience a rapid anabolic signal onset without the hormonal lag associated with medium- or long-chain esters such as enanthate or decanoate. Compared to single-ester propionate injections, the tri-ester combination of Ripped 150 provides overlapping bioavailability curves that reduce concentration troughs between injection days.

Bioavailability, PCT Timing, and Why Short Esters Change the Calculation

Ripped 150 establishes rapid systemic clearance as a protocol advantage, not merely a pharmacokinetic fact. Because all three esters are hydrolysed and metabolised within days — not weeks — HPG axis suppression begins to lift sooner than with long-ester blends, and PCT can be initiated approximately 3–5 days after the final injection. An aggressive SERM protocol is mandatory at this point; delaying PCT start beyond this window risks unnecessary suppression extending into recovery. Users should monitor LH, FSH, and total testosterone via blood panel before initiating PCT to confirm the clearance window has been reached. Magnus Pharmaceuticals' 10ml vial format, containing 1,500mg of total active ingredient, is formulated to maintain concentration uniformity across the full vial volume — a stability requirement verified by per-batch HPLC and LAL endotoxin testing at the fill facility.

Usage

Verify the vial label and batch code on the Magnus Pharmaceuticals verification portal before the first draw — confirm the 150mg/ml tri-ester composition matches (Testosterone Propionate 50mg + Trenbolone Acetate 50mg + Drostanolone Propionate 50mg).
Allow the vial to reach room temperature before drawing; the oil-based carrier flows more smoothly at 20–22°C, improving injection precision.
Swab the rubber stopper with 70% isopropyl alcohol and allow to air-dry for 30 seconds before inserting the needle — this preserves sterility across multiple draws from the multi-dose vial.
Draw the prescribed volume using a 21-gauge needle for withdrawal; switch to a fresh 23–25 gauge needle for intramuscular injection to minimise injection-site discomfort caused by the oil vehicle.
Administer via deep intramuscular injection — gluteus medius, vastus lateralis, or deltoid — rotating sites across every-other-day administrations to optimise absorption surface area and reduce localised tissue fatigue.
Log each injection date and volume in a cycle journal; because all three esters have short half-lives, injection-day tracking is critical for calculating the exact 3–5 day clearance window and setting a precise PCT start date.

Warnings

Contraindications: Ripped 150 is contraindicated in individuals with known hypersensitivity to any of the three active compounds (Testosterone Propionate, Trenbolone Acetate, Drostanolone Propionate) or to any component of the oil-based carrier. It must not be used by individuals under 18 years of age, those with existing cardiovascular disease, uncontrolled hypertension, active liver pathology, or prostate/breast carcinoma. Women of childbearing potential should not use this product due to significant virilisation risk from all three androgenic compounds.

Side Effects: Androgenic effects — including acne, accelerated scalp hair thinning in genetically predisposed individuals, and increased body hair — are possible with all three compounds. Trenbolone Acetate carries an elevated risk of night sweats and cardiovascular strain, including elevated resting heart rate and reduced aerobic capacity. Testosterone Propionate contributes to oestrogen-related effects via aromatisation; Drostanolone Propionate is non-aromatising but androgenically potent. Injection-site discomfort is typical with propionate-esterified compounds and can be mitigated by site rotation.

Monitoring: Haematocrit, haemoglobin, blood pressure, and lipid panel (LDL/HDL ratio) should be assessed at baseline and at the midpoint of any cycle. Liver enzyme markers (ALT, AST) and PSA screening are recommended for cycles exceeding six weeks. The rapid bioavailability of all three esters means hormonal changes — both desired and adverse — manifest within 24–72 hours; any severe adverse cardiovascular signals require immediate cycle cessation.

PCT: An aggressive SERM protocol (e.g. Nolvadex or Clomid at clinically directed doses) is mandatory and should commence 3–5 days after the final Ripped 150 injection, aligned to the rapid clearance of the acetate and propionate esters. A blood panel confirming the onset of LH and FSH recovery is recommended before adjusting SERM dose. Failure to initiate PCT within the 3–5 day window may unnecessarily prolong HPG axis suppression despite short ester clearance.

Frequently asked questions

How soon after the last injection of Ripped 150 should PCT begin?: PCT should begin approximately 3–5 days after the final injection of Ripped 150. Because all three esters — Testosterone Propionate, Trenbolone Acetate, and Drostanolone Propionate — carry short carbon chains (2- or 3-carbon), de-esterification and plasma clearance occur within days. Waiting longer than 5 days risks extending HPG axis suppression unnecessarily. An aggressive SERM protocol is mandatory from day one of PCT.
What blood markers confirm that Ripped 150 has cleared and PCT can safely start?: LH, FSH, and total testosterone are the primary markers to assess before starting PCT. After the last Ripped 150 injection, LH and FSH should begin recovering as exogenous androgen levels fall. A blood panel drawn 3–5 days post-injection provides a practical confirmation window. If total testosterone remains suppressed at day 5, a SERM should be initiated regardless, as the short esters will have cleared by this point.
What happens pharmacologically if PCT is started too early — before ester clearance is complete?: Starting PCT while residual ester is still releasing active hormone creates a counterproductive overlap: circulating androgens continue suppressing LH and FSH even as a SERM attempts to stimulate their release. With Ripped 150's short esters this risk is minimal beyond 48 hours, but users who inject large volumes on the final day should still wait the full 3–5 day window to allow complete de-esterification before initiating the SERM protocol.
Why is Ripped 150's 150mg/ml concentration an advantage for precise per-compound dosing?: At 150mg/ml — the lowest concentration in its product category — Ripped 150 delivers exactly 50mg per compound per ml, making dose calculation straightforward and injection volumes manageable. Users targeting 150mg total per injection draw precisely 1ml; those splitting doses to every-other-day can administer 0.5ml, yielding 25mg of each compound. This clarity reduces measurement error and supports consistent bioavailability across each injection day.
How should a 10ml vial of Ripped 150 be stored after the first puncture to maintain solution integrity?: After the first puncture, Ripped 150 should be stored at room temperature away from direct light and heat sources — refrigeration is not required and can increase oil viscosity, making withdrawal more difficult. The rubber stopper maintains multi-dose integrity; however, the vial should be used within the manufacturer's recommended period once opened. Inspect the solution before each draw: any cloudiness or particulates indicate the vial should be discarded immediately. (2) angle_used

Manufacturer

The packaging and vial-configuration decisions behind Magnus Pharmaceuticals' injectable range reflect a deliberate engineering rationale — one that is particularly visible in a multi-compound product like Ripped 150. Choosing a 10ml multi-dose vial format for a tri-ester formulation is not incidental: it requires the oil-based solution to maintain uniform compound distribution and concentration stability across repeated punctures and across the vial's full usable volume. Magnus Pharmaceuticals addresses this requirement through a fill-and-finish process in which homogeneity testing — confirming that each 1ml draw contains the specified 50mg of each compound — is performed at multiple draw-point intervals during batch sampling, not only at the first fill. The 10ml format also imposes a more demanding sterility standard than single-dose ampoules, because the stopper and headspace must maintain a contamination-free environment through the final draw. Magnus's QA documentation for Ripped 150 includes per-batch LAL endotoxin testing and HPLC compound-fraction quantification results, both of which are recorded at batch level and available to authorised distributors on request. This vial-centric quality architecture distinguishes Magnus Pharmaceuticals' multi-dose injectable presentation from single-ampoule competitors who do not bear the repeated-access sterility burden.

Product details

Brand	Magnus Pharmaceuticals
Active ingredient	mix product
Also known as	Steroid-Mix, Mehrkomponenten-Mischung, Cut Mix, Gain Mix, Ripped 150, Magnus Pharmaceuticals Steroid-Mix
Strength	150 mg
Form	Vial
Pack size	1 piece
Item number	INJ-MIX-MAG-150-006

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Mixobolin-200 200mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Hardcore Cutting

Mixobolin-200 200mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Mixobolin-200 by BM Pharmaceuticals combines Trenbolone Acetate 50mg, Drostanolone Propionate 50mg, and Testosterone Propionate 100mg per millilitre — 200mg/ml total — across 10 individually sealed single-dose glass ampoules, formulated to distribute androgen receptor occupancy across three mechanistically distinct compound classes rather than concentrating binding pressure through a single high-affinity pathway. All three propionate and acetate esters clear within 2–3 days, allowing cycle termination to be executed precisely when training output signals diminishing receptor responsiveness, with post-cycle therapy starting as early as 3–5 days after the final ampoule. Per-compound HPLC quantification and LAL endotoxin screening are applied at batch level; each ampoule is hermetically sealed under nitrogen-blanketed aseptic fill conditions before carton assembly.

€76.00

Recomp Optimizer

Mix Products Injection 250mg/ml 10ml Vial by Genesis

Genesis Mix Products Injection is a 250mg/ml tri-ester hybrid injectable combining Trenbolone Acetate 40mg, Nandrolone Decanoate 90mg, and Testosterone Mix 120mg per ml, formulated specifically to support precise microdosing protocols in a 10ml multi-dose vial. The dual 19-nor structure combined with a testosterone base makes post-cycle therapy exceptionally demanding — users must expect an aggressive, extended SERM regimen beginning approximately 14–21 days after the final injection, timed to the decanoate ester's clearance. Vial integrity, concentration accuracy, and sterility are verified through reversed-phase HPLC quantification and LAL endotoxin testing; every released batch carries a traceable certificate of analysis.

€54.00

Mass Building

NTD 400 400mg/ml 10ml Vial by GenTec

GenTec NTD 400 is a 400mg/ml tri-ester injectable blend — Nandrolone Decanoate 100mg, Drostanolone Enanthate 100mg, Testosterone Enanthate 200mg — formulated specifically for cruise & blast mass-building protocols in a 10ml multi-dose vial. Each millilitre delivers 4,000mg of total active ingredient across the full vial, with long-acting esters sustaining stable plasma levels throughout extended blast phases without the need for daily injections. Quality assurance is enforced through HPLC concentration verification, LAL endotoxin testing, and GMP-compliant aseptic fill-and-finish; batch certificates are available per lot.

€50.00

Best Value

Cut Stack 150 150mg/ml 10ml Vial by Hilma Biocare

Cut Stack 150 by Hilma Biocare is a 150mg/ml injectable cutting blend — Testosterone Propionate 50mg/ml, Trenbolone Acetate 50mg/ml, and Drostanolone Propionate 50mg/ml — supplied in a 10ml multi-dose vial and formulated exclusively for advanced cutting protocols, with an absolute contraindication against TRT or anti-aging use. Because all three compounds carry a 2–3 day half-life, plasma levels fall to sub-suppressive thresholds within days of the final injection, opening the post-cycle recovery window approximately 3–5 days after the last dose — a materially earlier point than long-ester injectable cycles, and driven by ester hydrolysis rather than the hepatic clearance kinetics that govern oral-cycle PCT scheduling. Every production lot is released under Hilma Biocare's analytical framework: HPLC potency confirmation and LAL endotoxin testing applied batch-by-batch, with certificates accessible via the brand's verification portal.

€54.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00